You are here: Home » PTI Stories » National » News
Business Standard

Lundbeck launches antidepressant in India

Press Trust of India  |  New Delhi 

Drug firm Thursday said it has launched in Brintellix tablets, which are used for treatment of Major Disorder.

The company has launched the drug after getting approval from the of (DCGI), said.

"We are pleased to be able to offer a new treatment option to the patients with which can address all the symptoms of depression, helping the patient to function better," India said.

is a that involves mood, physical and cognitive symptoms, he added.

Lundbeck is a Denmark-based pharma company.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Thu, October 11 2018. 18:15 IST